TECELRA 10000000000 1/1
afamitresgene autoleucel · INJECTION, SUSPENSION · USWM CT, LLC
TECELRA is a injection, suspension containing afamitresgene autoleucel at 10000000000 1/1, taken intravenous. Manufactured by USWM CT, LLC.
Key Facts
- Brand Name
- TECELRA
- Generic Name
- afamitresgene autoleucel
- NDC Code (Product)
87262-160- Manufacturer
- USWM CT, LLC
- Strength
- 10000000000 1/1
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125789
- Marketing Start
- 01/19/2026
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is TECELRA used for?
TECELRA contains afamitresgene autoleucel. It is a injection, suspension taken intravenous. Consult your doctor for specific uses.
Is TECELRA a controlled substance?
TECELRA is not classified as a controlled substance by the DEA.
What is the generic name for TECELRA?
The generic name for TECELRA is afamitresgene autoleucel. There are no other listed brand versions of afamitresgene autoleucel.
What is the NDC code for TECELRA 10000000000 1/1?
The NDC (National Drug Code) for TECELRA 10000000000 1/1 is 87262-160, listed by USWM CT, LLC.
Other TECELRA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)